Marshall Wace
MEDP icon

Marshall Wace’s Medpace MEDP Stock Holding History

Marshall Wace’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
29,182
+19,329
+196% +$8.92M 0.01% 839
2026
Q1 		$4.73M Sell
9,853
-35,098
-78% -$18M ﹤0.01% 1337
2025
Q4 		$25.2M Buy
44,951
+38,359
+582% +$21.8M 0.02% 554
2025
Q3 		$3.39M Buy
6,592
+5,623
+580% +$2.46M ﹤0.01% 1362
2025
Q2 		$304K Sell
969
-2,400
-71% -$721K ﹤0.01% 2319
2025
Q1 		$1.03M Sell
3,369
-11,065
-77% -$3.72M ﹤0.01% 1770
2024
Q4 		$4.8M Buy
+14,434
New +$4.9M 0.01% 1081
2024
Q2 		– Sell
-65,253
Closed -$26.4M – 2788
2024
Q1 		$26.4M Sell
65,253
-2,580
-4% -$907K 0.04% 421
2023
Q4 		$20.8M Sell
67,833
-23,889
-26% -$6.45M 0.04% 475
2023
Q3 		$22.2M Sell
91,722
-60,599
-40% -$15.5M 0.05% 400
2023
Q2 		$36.6M Buy
+152,321
New +$31.6M 0.07% 287
2023
Q1 		– Sell
-7,300
Closed -$1.55M – 2935
2022
Q4 		$1.55M Buy
+7,300
New +$1.46M ﹤0.01% 1863
2020
Q1 		– Sell
-7,395
Closed -$621K – 1890
2019
Q4 		$621K Sell
7,395
-97,392
-93% -$7.54M ﹤0.01% 1103
2019
Q3 		$8.81M Sell
104,787
-89,950
-46% -$6.8M 0.07% 328
2019
Q2 		$12.7M Buy
194,737
+193,060
+11,512% +$11.1M 0.1% 221
2019
Q1 		$99K Buy
+1,677
New +$100K ﹤0.01% 1436
2018
Q2 		– Sell
-12,800
Closed -$447K – 781
2018
Q1 		$447K Buy
+12,800
New +$468K 0.02% 392
2016
Q4 		– Sell
-32,465
Closed -$969K – 1063
2016
Q3 		$969K Buy
+32,465
New +$948K 0.01% 726

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Marshall Wace's MEDP Position: Q2 2026 in Review

Marshall Wace increased its Medpace (MEDP) stake by 196% in Q2 2026, buying an estimated $8.92M and bringing the position to 29,182 shares worth $15.5M. The position accounts for 0.01% of the portfolio, ranked #839.

Marshall Wace first reported a position in MEDP in Q3 2016 and has held it in 18 quarters since. The position peaked at $36.6M in Q2 2023. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Marshall Wace held 29,182 shares of Medpace worth $15.5M as of Q2 2026.
  • Marshall Wace bought 19,329 Medpace shares in Q2 2026, an estimated $8.92M.
  • Medpace made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #839 holding.
  • Marshall Wace first reported a position in Medpace in Q3 2016 and has held it in 18 quarters since.
  • Marshall Wace's Medpace position peaked at $36.6M in Q2 2023.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.